TSXV · NLH.V
Nova Leap Health Corp.
CA$0.53+CA$0.03 (+6.0%)
Nova Leap Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 11.67% below the high.
Loading market information…
OTC · MBGNF · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Many Bright Ideas Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Many Bright Ideas Technologies Inc.’s next earnings report is currently expected on Nov 27, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Many Bright Ideas Technologies Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Many Bright Ideas Technologies Inc. (MBGNF) currently operates with minimal business activity. This Vancouver-based company, founded in 2006, adopted its current name in June 2022, having previously been known as Med BioGene Inc. Historically, its focus was within the life sciences sector, specifically dedicated to developing and bringing to market genomic diagnostic solutions for non-small-cell lung cancer. Although its operations are currently limited, the company's stated strategic objective is to commercialize various technologies across a range of industrial sectors.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:47 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.53+CA$0.03 (+6.0%)
Nova Leap Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 11.67% below the high.
$0.03-$0.00 (-14.0%)
CareView Communications, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.38% below the high.
$0.15+$0.01 (+3.53%)
Guided Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 72.22% below the high.
$0.03-$0.00 (-6.58%)
United Health Products, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.58% below the high.
CA$0.14-CA$0.01 (-3.45%)
Izotropic Corporation’s quoted price sits in the lower half of its reported 52-week range, 70.21% below the high.
SEK 0.05+SEK 0.01 (+13.86%)
Immunovia AB’s quoted price sits in the lower half of its reported 52-week range, 85.91% below the high.
$0.12$0.00 (0.0%)
Hadasit Bio-Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 7.69% below the high.
$0.00$0.00 (0.0%)
Molecule Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
